| Development of epitope‐based peptide vaccine against novel Coronavirus 2019 (SARS‐COV‐2): Immunoinformatics approach M Bhattacharya, A Ranjan Sharma, P Patra, P Ghosh, G Sharma, ... Journal of Medical Virology, 2020 | 416 | 2020 |
| SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options. C Chakraborty, AR Sharma, G Sharma, M Bhattacharya, SS Lee European Review for Medical & Pharmacological Sciences 24 (7), 2020 | 362 | 2020 |
| A detailed overview of SARS-CoV-2 omicron: its sub-variants, mutations and pathophysiology, clinical characteristics, immunological landscape, immune escape, and therapies S Chatterjee, M Bhattacharya, S Nag, K Dhama, C Chakraborty Viruses 15 (1), 167, 2023 | 233 | 2023 |
| CRISPR-Cas9: a preclinical and clinical perspective for the treatment of human diseases G Sharma, AR Sharma, M Bhattacharya, SS Lee, C Chakraborty Molecular Therapy 29 (2), 571-586, 2021 | 224 | 2021 |
| Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier G Sharma, AR Sharma, SS Lee, M Bhattacharya, JS Nam, C Chakraborty International journal of pharmaceutics 559, 360-372, 2019 | 184 | 2019 |
| Probable molecular mechanism of remdesivir for the treatment of COVID-19: need to know more A Saha, AR Sharma, M Bhattacharya, G Sharma, SS Lee, C Chakraborty Archives of Medical research 51 (6), 585, 2020 | 168 | 2020 |
| The drug repurposing for COVID-19 clinical trials provide very effective therapeutic combinations: Lessons learned from major clinical studies C Chakraborty, AR Sharma, M Bhattacharya, G Agoramoorthy, SS Lee Frontiers in Pharmacology, 2942, 2021 | 146 | 2021 |
| Present variants of concern and variants of interest of severe acute respiratory syndrome coronavirus 2: Their significant mutations in S‐glycoprotein, infectivity, re … C Chakraborty, M Bhattacharya, AR Sharma Reviews in Medical Virology, e2270, 2021 | 133 | 2021 |
| Repurposing drugs, ongoing vaccine, and new therapeutic development initiatives against COVID-19 RP Saha, AR Sharma, MK Singh, S Samanta, S Bhakta, S Mandal, ... Frontiers in pharmacology 11, 1258, 2020 | 131 | 2020 |
| A detailed overview of immune escape, antibody escape, partial vaccine escape of SARS-CoV-2 and their emerging variants with escape mutations C Chakraborty, AR Sharma, M Bhattacharya, SS Lee Frontiers in Immunology, 53, 2022 | 122 | 2022 |
| The 2019 novel coronavirus disease (COVID-19) pandemic: a zoonotic prospective C Chakraborty, AR Sharma, M Bhattacharya, G Sharma, SS Lee Asian Pacific Journal of Tropical Medicine 13 (6), 242-246, 2020 | 118 | 2020 |
| Tocilizumab: a therapeutic option for the treatment of cytokine storm syndrome in COVID-19 A Saha, AR Sharma, M Bhattacharya, G Sharma, SS Lee, C Chakraborty Archives of medical research 51 (6), 595, 2020 | 111 | 2020 |
| Extensive partnership, collaboration, and teamwork is required to stop the COVID-19 outbreak C Chakraborty, AR Sharma, G Sharma, M Bhattacharya, RP Saha, ... Archives of medical research 51 (7), 728-730, 2020 | 107 | 2020 |
| From COVID-19 to cancer mRNA vaccines: moving from bench to clinic in the vaccine landscape C Chakraborty, AR Sharma, M Bhattacharya, SS Lee Frontiers in Immunology 12, 679344, 2021 | 99 | 2021 |
| COVID‐19: Consider IL‐6 receptor antagonist for the therapy of cytokine storm syndrome in SARS‐CoV‐2 infected patients C Chakraborty, AR Sharma, M Bhattacharya, G Sharma, SS Lee, ... Journal of medical virology 92 (11), 2260-2262, 2020 | 98 | 2020 |
| Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4/MD-2 complex M Bhattacharya, AR Sharma, B Mallick, G Sharma, SS Lee, ... Infection, Genetics and Evolution 85, 104587, 2020 | 91 | 2020 |
| MicroRNAs mediated regulation of MAPK signaling pathways in chronic myeloid leukemia C Chakraborty, AR Sharma, BC Patra, M Bhattacharya, G Sharma, ... Oncotarget 7 (27), 42683, 2016 | 87 | 2016 |
| Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach A Choudhury, NC Das, R Patra, M Bhattacharya, P Ghosh, BC Patra, ... Future Virology 16 (4), 277-291, 2021 | 85 | 2021 |
| A domain-specific next-generation large language model (LLM) or ChatGPT is required for biomedical engineering and research S Pal, M Bhattacharya, SS Lee, C Chakraborty Annals of biomedical engineering 52 (3), 451-454, 2024 | 81 | 2024 |
| DNA barcoding to fishes: current status and future directions M Bhattacharya, AR Sharma, BC Patra, G Sharma, EM Seo, JS Nam, ... Mitochondrial DNA Part A 27 (4), 2744-2752, 2016 | 79 | 2016 |
Chiranjib Chakraborty, Ph.DChair Professor, School of Life Science and Biotechnology, Adamas University, India在 adamasuniversity.ac.in 的电子邮件经过验证
